Eli Lilly’s New Weight-Loss Drug Receives U.K. Marketing Authorization, Securing Another Milestone in European Market Expansion Aug 11, 2026 Life Science
Anthropic Locks In Riot Data Center Capacity with $9.1 Billion Deal Aug 11, 2026 Cryptocurrency, Life Science, Technology
Eli Lilly Locks In Retatrutide FDA Filing Date — Can the Stock Climb to $1,750 by 2027? Aug 7, 2026 Life Science
AbbVie Lowers Full-Year Profit Guidance, Investor Disappointment Triggers Stock Sell-Off Aug 1, 2026 Life Science
Bristol-Myers Squibb Beats Estimates in Q2, Stock Outperforms Market on Thursday Jul 31, 2026 Life Science
Weight-Loss Pipeline in Focus: Viking Therapeutics Could Be the Next Acquisition Target Jul 30, 2026 Life Science
Seize the Golden Window for Biotech IPOs, Attovia Aims to Raise Up to $212.5 Million in Nasdaq Debut Jul 29, 2026 Life Science
Johnson & Johnson Quietly Completes Strategic Pivot, Targeting $50 Billion Cancer Drug Blueprint Jul 29, 2026 Life Science
Can Amgen’s Monthly Obesity Shot Rattle the Eli Lilly-Novo Nordisk Duopoly? Jul 29, 2026 Life Science
Capital Expenditure Surge Reshapes Market Landscape as Funds Flee Tech Stocks for Value Opportunity in Healthcare Jul 27, 2026 Life Science, Technology
Moderna’s Market Value Exceeds Twenty Billion Dollars, Yet Ongoing Operating Losses and Competitive Pressures Continue to Trouble Investors Jul 27, 2026 Life Science
Bristol-Myers Squibb’s High Dividend Temporarily Backed by Financial Support, but Patent Cliff Poses Future Concerns Jul 25, 2026 Life Science
